The psychedelic that breaks opioid addiction in a single session — now a token. 200M permanently burned. Surfacing from underground, holder by holder.
Ibogaine is a psychoactive alkaloid from the iboga plant of West Africa. It's known for one extraordinary clinical effect: interrupting opioid withdrawal in a single session.
Where conventional medicine takes weeks of tapering and years of follow-up, ibogaine resets the brain's reward circuits in around 36 hours. People wake up with the cravings gone — and often with deeper insights into what was driving them in the first place.
It's currently Schedule I in the United States. Legal in Mexico, New Zealand, and Brazil, where licensed clinics treat opioid addicts, war veterans, and survivors of profound trauma.
The research is gathering momentum. The underground keeps the candle lit.
"The wood that opens the head."
— how the Fang people of Gabon describe iboga, used in initiation ceremonies for centuries before Western researchers arrived.
This isn't a product. It's not a company. It's a meme — a way to put a small bet on a research story you believe is coming.
Psilocybin spent thirty years underground before emerging into mainstream therapy. MDMA's been close to FDA approval for PTSD. Ibogaine is next in the queue, with one of the strongest clinical case files of any psychedelic alive.
Memecoins are how culture votes on attention. $IBOGAINS is just a small contract on the Solana-fork chain X1 — token-2022, freeze authority revoked, 200M of supply already burned. The rest is what the market does with it.
Not financial advice. Not medical advice. The medicine doesn't need this token to do its work — but the token can help the conversation reach more of the people who need it.